PT  - JOURNAL ARTICLE
AU  - Y J Anupama
AU  - Arvind Conjeevaram
AU  - A Ravindra Prabhu
AU  - Manjunath Doshetty
AU  - Sanjay Srinivasa
AU  - Venkatesh Moger
TI  - Impact of COronaVirus Disease-2019 (COVID-19) pandemic on Haemodialysis care delivery pattern in Karnataka, India - a cross-sectional, questionnaire based survey
AID  - 10.1101/2020.07.25.20151225
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.25.20151225
4099  - http://medrxiv.org/content/early/2020/07/27/2020.07.25.20151225.short
4100  - http://medrxiv.org/content/early/2020/07/27/2020.07.25.20151225.full
AB  - The COVID-19 pandemic has disrupted health care delivery globally. Patients on in-centre haemodialysis(HD) are particularly affected due to their multiple hospital visits and the need for uninterrupted care for their well-being and survival. We studied the impact of the pandemic and the national policy for pandemic control on the HD care delivery in Karnataka state in India in April 2020, when the first and second national lockdown were in place. An online, questionnaire based survey of dialysis facilities was conducted and the responses analysed. The questions were pertaining to the key areas such as changes in number of dialysis treatments, frequency, duration, expenses, transportation to and from dialysis units, impact on availability of consumables, effect on dialysis personnel and on machine maintenance. 62 centres participated. Median of dialysis treatments for the months of March and April 2020 were 695.5 and 650 respectively. Reduction in dialysis treatments was noted in 29(46.8%) facilities, decreased frequency reported by 60 centres. In at least 35(56.5%) centres, dialysis patients had to bear increased expenses. Cost and availability of dialysis consumables were affected in 40(64.5%) and 55(88.7%) centres respectively. Problems with transportation and movement restriction were the two key factors affecting both patients and dialysis facilities.This survey documents the collateral impact of COVID-19 on the vulnerable group of patients on HD, even when not affected by COVID. It identifies the key areas of challenges faced by the patients and the facilities and implores the care-providers for finding newer avenues for mitigation of the problems.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot registered since it is a cross-sectional, questionnaire based surveyFunding StatementNot fundedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Nanjappa Institutional Ethics Committee, Nanjappa Life care Shivamogga 577201 IndiaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable on request